These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1361960)

  • 1. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
    Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
    Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.
    Robuschi M; Gambaro G; Spagnotto S; Scuri M; Fai V; Lodola E; Pisati R; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):407-11. PubMed ID: 1684178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
    Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
    Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of broxaterol by cultured human cells.
    Parenti P; Cappelletti G; Fornasini G; Galimberti C; Hanozet G
    Biochem Int; 1992 Nov; 28(3):467-74. PubMed ID: 1362350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
    Robuschi M; Scuri M; Spagnotto S; Gambaro G; Lodola E; Pisati R; Bianco S
    Eur J Clin Pharmacol; 1995; 47(5):465-6. PubMed ID: 7720771
    [No Abstract]   [Full Text] [Related]  

  • 13. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
    Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
    Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
    Giustina A; Malerba M; Bresciani E; Desenzani P; Licini M; Zaltieri G; Grassi V
    J Endocrinol Invest; 1995 Dec; 18(11):847-52. PubMed ID: 8778156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
    Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
    Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
    Tantucci C; Burni B; Dottorini ML; Malerba M; Peccini F; Gurrieri G; Sorbini CA; Grassi V
    Int J Clin Pharmacol Res; 1990; 10(3):183-9. PubMed ID: 1977709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood.
    Vangveeravong M
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S115-23. PubMed ID: 19253506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.